TG THERAPEUTICS, INC. Repayments of Short-term Debt
TG THERAPEUTICS, INC. (TGTX) reported Repayments of Short-term Debt of $200.00 thousand for the 25-month period ending 2013-12-31, per its 10-K filed 2014-03-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2014-03-07
- TG THERAPEUTICS, INC. repayments of short-term debt for the quarter ending 2013-12-31 was $0.00, a 100.00% decline year-over-year.
- TG THERAPEUTICS, INC. repayments of short-term debt for the quarter ending 2013-09-30 was $0.00.
- TG THERAPEUTICS, INC. repayments of short-term debt for the quarter ending 2013-06-30 was $0.00.
- TG THERAPEUTICS, INC. repayments of short-term debt for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- TG THERAPEUTICS, INC. repayments of short-term debt for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- TG THERAPEUTICS, INC. repayments of short-term debt for fiscal 2012 was $200.00K.
- TG THERAPEUTICS, INC. repayments of short-term debt for fiscal 2011 was $0.00.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month | Repayments of Short-term Debt 12 month | Repayments of Short-term Debt 13 month | Repayments of Short-term Debt 15 month | Repayments of Short-term Debt 16 month | Repayments of Short-term Debt 18 month | Repayments of Short-term Debt 19 month | Repayments of Short-term Debt 22 month | Repayments of Short-term Debt 25 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $0.00 derived: sum of 2 quarters · filed 2014-03-07 | $0.00 derived: sum of 3 quarters · filed 2014-03-07 | $0.00 10-K · filed 2014-03-07 | $200.00K 10-K · filed 2014-03-07 | ||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | $1.00 derived: sum of 4 quarters · filed 2014-03-07 | $200.00K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $0.00 10-Q · filed 2013-08-09 | $1.00 derived: sum of 3 quarters · filed 2014-03-07 | $1.00 derived: sum of 4 quarters · filed 2014-03-07 | $200.00K 10-Q · filed 2013-08-09 | ||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 | $1.00 derived: sum of 2 quarters · filed 2014-03-07 | $1.00 derived: sum of 3 quarters · filed 2014-03-07 | $1.00 derived: sum of 4 quarters · filed 2014-03-07 | $200.00K 10-Q · filed 2013-05-14 | ||||||
| 2012-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $1.00 derived: sum of 2 quarters · filed 2014-03-07 | $1.00 derived: sum of 3 quarters · filed 2014-03-07 | $200.00K 10-K · filed 2014-03-07 | $200.00K 10-K · filed 2013-03-21 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $200.00K 10-Q · filed 2013-11-14 | $200.00K derived: sum of 4 quarters · filed 2013-11-14 | $200.00K 10-Q · filed 2012-11-14 | ||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $200.00K 10-Q · filed 2013-08-09 | $200.00K derived: sum of 3 quarters · filed 2013-08-09 | $200.00K derived: sum of 4 quarters · filed 2013-08-09 | $200.00K 10-Q/A · filed 2012-09-07 | ||||||
| 2012-03-31 | $200.00K 10-Q · filed 2013-05-14 | $200.00K derived: sum of 2 quarters · filed 2013-05-14 | $200.00K derived: sum of 3 quarters · filed 2013-05-14 | $200.00K 10-Q · filed 2012-05-14 | |||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $0.00 derived: sum of 2 quarters · filed 2013-03-21 | $0.00 10-K · filed 2013-03-21 | ||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||||||
| 2011-06-30 | $0.00 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |